Varicella disease among vaccinated persons: Clinical and epidemiological characteristics, 1997-2005

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Chaves, Sandra S ^a   Zhang, John ^a   Civen, Rachel ^b   Watson, Barbara M ^c   Carbajal, Tina ^b   Perella, Dana ^c   Seward, Jane F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Los Angeles County Department of Public Health   (United States)

^c PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ATAXIA; CHICKENPOX; CONFERENCE PAPER; DEHYDRATION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENCEPHALITIS; HEALTH CARE PERSONNEL; HUMAN; OTITIS MEDIA; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SEPTICEMIA; SKIN DEFECT; SKIN INFECTION; STRUCTURED INTERVIEW; VACCINATION; VIRUS MENINGITIS;

ADOLESCENT; CALIFORNIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PENNSYLVANIA; POPULATION SURVEILLANCE; SEVERITY OF ILLNESS INDEX; VACCINATION;

EID: 42549114363     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522150     Document Type: Conference Paper

References (27)

1. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 2004; 113:455-9.
2. Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 1997; 278:1495-9.
3. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children - Michigan, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:389-92.
4. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatr Infect Dis J 1999; 18:1047-50.
5. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002; 347:1909-15.
6. Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 2006; 117:e1070-7.
7. Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S71-5 (in this supplement).
8. V́azquez M, LaRussa P, Gershon A, Steinberg S, Freudigman K, Shapiro E. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001; 344:955-60.
9. Bernstein HH, Rothstein EP, Watson BM, et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993; 92:833-7.
10. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91:17-22.
11. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-11.
12. Vollset SE. Confidence intervals for a binomial proportion. Stat Med 1993; 12:809-24 (erratum: Stat Med 1995; 14:875).
13. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J 2002; 21:931-5.
14. Guess HA, Broughton DD, Melton LJ III, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986; 78:723-7.
15. Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981; 68:14-7.
16. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172:706-12.
17. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992; 11:441-5.
18. Marin M, Watson TL, Chaves SS, et al. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S94-100 (in this supplement).
19. Nguyen H, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New Engl J Med 2005; 352:450-8.
20. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797-802.
21. Naruse H, Miwata H, Ozaki T, Asano Y, Namazue J, Yamanishi K. Varicella infection complicated with meningitis after immunization. Acta Paediatr Jpn 1993; 35:345-7.
22. Schwab J, Ryan M. Varicella zoster virus meningitis in a previously immunized child. Pediatrics 2004; 114:e273-4.
23. Sharrar RG, LaRussa P, Galea SA, et al. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19:916-23.
24. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40.
25. Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Study Group for Varivax. Pediatr Infect Dis J 2004; 23:132-7.
26. Ngai AL, Staehle BO, Kuter BJ, et al. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J 1996; 15:49-54.
27. Watson B, Rothstein E, Bernstein H, et al. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis 1995; 172:217-9.